Trial Profile
18F-AV-1451 PET Imaging in Professional Fighters
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Sep 2020
Price :
$35
*
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Alzheimer's disease; Cognition disorders
- Focus Diagnostic use
- Sponsors Avid Radiopharmaceuticals
- 13 Apr 2017 Status changed from recruiting to completed.
- 27 May 2016 Planned End Date changed from 1 Nov 2015 to 1 Jan 2017.
- 27 May 2016 Planned primary completion date changed from 1 Nov 2015 to 1 Jan 2017.